Contributors


Meredith Sherman

Latest:

Treating Cancer's Unknown

Providers spend a great deal of their time treating cancer, but how much time is being spent treating the patient?


Peter C. Adamson, MD

Latest:

Picking Up the Pace

Igniting progress in the cure of children with cancer.


Carol A. Miele

Latest:

Do Well-Meaning Friends of People With Cancer Always Mean Well?

A cancer diagnosis can sometimes stop a friendship in its tracks.


Alyssa Castro

Latest:

The Force Is Strong With Cancer Survivors: Joining My Rebel Alliance

When I was diagnosed with Hodgkin's lymphoma, I envisioned myself in a galaxy far, far away. Just like any well-trained Jedi, I fought back when insurance denied my claim for doctor-recommended treatment.



Michael Birrer, M.D., Ph.D.

Latest:

Ask an Expert: How Do PARP Inhibitors Work?

PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.


Colon Cancer Coalition

Latest:

Colorectal Cancer Patients Should Not Assume that Care is Unavailable

People experiencing gastrointestinal symptoms or delays in colorectal cancer care should address these questions with their care team.


Kelley Kramer

Latest:

My Oncology Nurse Is a Soul Healer

An Extraordinary Healer essay honoring MARJORIE CASTO THEILIG, RN-BC, B.S.N. [MD ANDERSON CANCER CENTER AT COOPER, VOORHEES TOWNSHIP, NEW JERSEY]



Ishwaria Mohan Subbiah

Latest:

Ishwaria Mohan Subbiah on Older Patients Enrolled in Clinical Trials

Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.


Nosayaba Osazuwa-Peters, BDS, MPH, CHES

Latest:

Focusing on Improving Depression in HNC Survivors

As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.


Sandra Hanner

Latest:

Pancreatic Cancer Survival Rates Lower in Real World Versus Clinical Trials

In the analysis, there was as much as a 92 percent difference in median overall survival (OS) seen between patients treated in randomized controlled trials and "real world" data.


Holly Johnson, MD

Latest:

My Extraordinary Healer

We are all healers of the world no matter who we are. We are here because we can make a difference.


Kerry Lengyel

Latest:

When Treating Your Skin Cancer, Protect Your Pets

Creams containing the chemotherapy 5-fluorouracil can be fatal to animals, the FDA warns.


Pippa Wysong

Latest:

Trial Run: What You Need to Know About Clinical Trials in Canada

Clinical trials offer a chance to try experimental treatments and move the state of science forward. Here’s what patients need to know.


Ethan Zohn

Latest:

Ethan Zohn: Cancer Treatment is "A Marathon, Not a Sprint"

“Survivor: Africa” winner Ethan Zohn details his journey with cancer and discovering that it isn’t a sprint, but a marathon.


Mazyar Shadman

Latest:

What Factors Play a Role in Determining Optimal First Line Treatment for Patients With CLL

There are three things that should be considered when deciding what is the optimal treatment in the first line setting for patients with chronic lymphocytic leukemia (CLL), according to Dr. Mazyar Shadman.


Stephanie Sandler

Latest:

Redefining Success After Breast Cancer

Breast cancer was one of the best things that ever happened to me – and I never want it again. Now I am cancer-free and living a more fulfilling life than before the illness. Here are 10 insights and experiences from my cancer journey that continue to sustain me professionally and personally.


Claudia Craemer-Meihsner as told to Eric Ness

Latest:

Now That I'm An Adult

A reader shares her childhood story of having a parent with cancer.


Christopher Schultz

Latest:

Coping

Breaking the news of cancer diagnosis—how siblings react to the disease.


DONNA R. WHITE, DNP, RN, CRNP, FNP-BC

Latest:

Promoting BRCA Awareness

Despite living in a pink world, genetic testing is important for all genders to assess individual and family risk.



Tom Siegfried

Latest:

Mutations & Math

Could using game theory help us understand cancer?


Diana Gordon, RN, MSN, CPNP, CPON

Latest:

Diana Gordon on Dealing With Insurance Companies

Diana Gordon, RN, MSN, CPNP, CPON, Division of Pediatric Hematology Oncology, University of North Carolina-Chapel Hill, and one of our 2016 Extraordinary Healer Award finalists, discusses dealing with insurance companies.


Dr. Kathryn Ruble

Latest:

How Patients with Cancer and Survivors Can Maintain Good Sleep Hygiene Through the COVID-19 Pandemic

Sleep is important to everyone, especially for patients with cancer as they recover from treatment. But as many people are currently learning, rest is sometimes hard to come by while navigating the global COVID-19 pandemic.


Juergen Klenk

Latest:

Juergen Klenk on the Cancer XPRIZE

Juergen Klenk of Deloitte Consulting discusses their partnership with the XPRIZE foundation to build a cancer XPRIZE competition.





Tara Haelle

Latest:

A Paradigm Shift in the Treatment of Early-Stage Lung Cancer May Be Leading to More Cures

Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, according to experts, may be transformative for patients.